🔗 Permalink

Inventor profile of:

Peter Krammer

City:

Heidelberg

Country:

Germany

Published Applications:

Last publication date:

2022-05-19

Top Assignees for applications by Peter Krammer

The entities that hold a legal rights for patent applications filed by inventor Krammer Peter:

Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts 3 Heidelberg, Germany
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTES 2 Heidelberg, Germany
Deutsches Krebsforschungszentrum Stiftung des offentlichen Rechts 1 Heidelberg, Germany

Recent patent applications by Krammer Peter

Peter Krammer from Heidelberg, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-05-19

US20220152149A1

Human necessities

Annexin-coated particles

#2 | 2021-07-29

US20210230238A1

Chemistry; metallurgy

Core domain of annexins and uses thereof in antigen delivery and vaccination

#3 | 2021-06-03

US20210161851A1

Human necessities

COMBINATION THERAPY OF LYMPHOMA

#4 | 2020-12-10

US20200385738A1

Chemistry; metallurgy

H-1 PV EXPRESSING RNAI EFFECTORS TARGETING CDK9

#5 | 2019-05-16

US20190144513A1

Chemistry; metallurgy

Core domain of annexins and uses thereof in antigen delivery and vaccination

#6 | 2018-06-21

US20180169123A1

Human necessities

COMBINATION THERAPY WITH A FLAVAGLINE AND 2-DEOXYGLUCOSE

#7 | 2017-01-05

US20170002352A1

Chemistry; metallurgy

Inhibitors of thioredoxin-interacting protein (TXNIP) for therapy

#8 | 2016-06-09

US20160158189A1

Human necessities

SENSITIZATION OF CANCER CELLS TO APOPTOSIS INDUCTION BY FLAVAGLINES AND 5-HYDROXY-FLAVONES

#9 | 2016-04-28

US20160113958A1

Human necessities

MODULATORS OF ADP-DEPENDENT GLUCOKINASE (ADPGK) AND GLYCEROL-3-PHOSPHATE DEHYDROGENASE (GPD2) FOR THERAPY

#10 | 2015-06-04

US20150152169A1

Chemistry; metallurgy

Inhibitors of thioredoxin-interacting protein (TXNIP) for therapy

#11 | 2014-06-19

US20140171624A1

Chemistry; metallurgy

MODULATORS OF ADP-DEPENDENT GLUCOKINASE (ADPGK) AND GLYCEROL-3-PHOSPHATE DEHYDROGENASE (GPD2) FOR THERAPY

#12 | 2007-09-06

US20070207160A1

Chemistry; metallurgy

Apoptosis inhibitors

#13 | 2006-10-19

US20060234968A1

Chemistry; metallurgy

Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries

InventorID:

807163 ⎘